Micro Aftermath Active

Persetujuan FDA untuk Dosis Wegovy yang Lebih Tinggi oleh Novo Nordisk

Activity declining — narrative losing relevance.

Skor
0,3
Kecepatan
▲ 0,0
Artikel
14
Sumber
3

Sentiment Timeline

Event Timeline

Apr 02, 2026
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison Bullish
Apr 01, 2026
Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England Bullish
Mar 31, 2026
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries … Neutral
Mar 28, 2026
Novo Nordisk: A Strong Contender in the Pharmaceutical Arena Bullish
Mar 26, 2026
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to … Neutral
Mar 23, 2026
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on … Neutral
Mar 21, 2026
This Hims & Hers Move Could Destroy Competitors Bullish
Mar 20, 2026
Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss … Neutral
Mar 19, 2026
FDA approves higher dose version of weight loss drug Wegovy as Novo … Neutral

Artikel Terkait

Novo Nordisk's Wegovy Approved For Cardiovascular Event Risk Reduction In England

Nasdaq · Apr 01, 2026
Mixed

Could This New Approval Be a Turning Point For Novo Nordisk?

Nasdaq · Apr 01, 2026
Mixed

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to …

CNBC · Mar 23, 2026
Mixed

This Hims & Hers Move Could Destroy Competitors

Nasdaq · Mar 21, 2026
Mixed

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

Nasdaq · Mar 20, 2026
Bearish

Are GLP-1s tax deductible? How to deduct Ozempic, Wegovy, and other weight-loss drugs.

Yahoo Finance · Mar 20, 2026
Mixed

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to …

CNBC · Mar 19, 2026
Mixed

Lini Waktu

Pertama TerlihatMar 19, 2026
Terakhir DiperbaruiMar 19, 2026